GlycoNet Investigator Dr. Chantelle Capicciotti, from Queen’s University, has been recognized as a Tier 2 Canada Research Chair (CRC) in Chemical Biology, a prestigious honor awarded to emerging leaders in research. Supported by $500,000 in funding over five years, Tier 2 CRCs are integral to Canada’s strategy to foster groundbreaking research and innovation.

Using interdisciplinary techniques in chemistry, biochemistry and cell biology, Dr. Capicciotti’s work focuses on glycan research, exploring the complex carbohydrates, or sugars, that coat all cells. Her efforts aim to develop efficient synthesis methods and tools to study glycan-protein interactions, answering fundamental questions in cellular biology and advancing the development of more effective medicines to treat disease.

The Canada Research Chair program, established in 2000, recognizes outstanding researchers across the country. Dr. Capicciotti’s achievement highlights the impact and promise of her work in addressing critical scientific challenges and contributing to global advancements in health and medicine.

Related News:

• Exterior cell surface design with glyco-engineering